Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Aloop Therapeutics ApS
APS
Active
Advertising protection
CVR 43257498
Sundkrogsgade 21, 2100
København Ø
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 4 years old
6 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Aloop Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
RC
Rodolphe Clerval
Chief Executive Officer
Chief Executive Officer
2025
Former (2)
TK
Thomas Kirkegaard Jensen
Management
Management
2022 – 2024
SS
Søren Sylvester Skjærbæk
Chief Executive Officer
Chief Executive Officer
2022 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Former (3)
EC
Emmanuelle Coutanceau
Board of Directors
Board of Directors
2022 – 2025
JB
Jens Bo Rode Hansen
Chairman
Chairman
2022 – 2023
CP
Camilla Petrycer Hansen
Chairman
Chairman
2023 – 2025
Shareholders
As of last annual report
Coave Therapeutics — 100%
Novo Holdings A/S — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Coave Therapeutics
Individual
100%
100%
2025
Novo Holdings A/S
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Aloop Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network